Progression of chronic adriamycin nephropathy in leukopenic rats

F. Ginevri, A. Trivelli, A. Mutti, E. Bergamaschi, G. Fabbretti, F. Callea, G. Salvidio, P. Altieri, F. Perfumo, G. M. Ghiggeri

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

In this study, we examined the progression of chronic Adriamycin (ADR) nephropathy in mild leukopenic rats and tried to define the possible relationship between tubulointerstitial lesions and proteinuria in this model. Chronic ADR nephropathy was induced by 2 doses of ADR (2mg/kg) in 32 Sprague-Dawley rats. Eight of these were randomly assigned to cyclophosphamide treatment (50mg/kg), given intravenously every week, to keep the blood leukocyte count constantly lower than 5,000/mm3. Serial parameters were followed for 16 weeks including clearance studies with iothalamate and p-aminohippurate and the analysis of urinary protein composition by: (a) an enzymatic assay for β-glucosidase; (b) specific ELISA using antibodies against rat albumin and RBP, and finally (c) two-dimensional electrophoresis. ADR-treated rats rapidly (within 2 weeks) developed massive proteinuria which was in constant increment throughout the disease evolution in each single component (i.e., high and low molecular weight proteinuria, enzymuria) and developed renal insufficiency. At week 8, in ADR rats, glomerulosclerosis was mild whereas tubulointerstitial infiltrates predominated, characterized mainly by CD4 + T lymphocytes while CD8 + T lymphocytes were inconspicuous, and macrophages were only occasionally present. All such alterations had worsened after 16 weeks when the tubulointerstitial infiltration was associated with marked interstitial fibrosis and tubular atrophy. Leukopenia induced by cyclophosphamide was in all cases associated with a net amelioration of renal histopathology reducing tubulointerstitial infiltrates (by 40%) and glomerulosclerosis (33±5 vs. 52.2±7.5% sclerotic glomeruli) and also ameliorated glomerular filtration indexes (C(I) 780±40 vs. 447±66μl/min/kg-1). In spite of these differences, albuminuria and urinary-retinol-binding protein were comparable at weeks 4, 8 and 16 in this group, while urinary β-glucosidase was decreased at week 16 (p

Original languageEnglish
Pages (from-to)79-88
Number of pages10
JournalNephron
Volume63
Issue number1
Publication statusPublished - 1993

Fingerprint

Doxorubicin
Proteinuria
Glucosidases
Cyclophosphamide
Iothalamic Acid
p-Aminohippuric Acid
T-Lymphocytes
Retinol-Binding Proteins
Albuminuria
Leukopenia
Enzyme Assays
Leukocyte Count
Atrophy
Renal Insufficiency
Sprague Dawley Rats
Electrophoresis
Albumins
Fibrosis
Molecular Weight
Enzyme-Linked Immunosorbent Assay

Keywords

  • Adriamycin nephropathy
  • Leukopenic rats
  • Progression of renal disease
  • Proteinuria
  • Tubulointerstitial fibrosis

ASJC Scopus subject areas

  • Nephrology

Cite this

Ginevri, F., Trivelli, A., Mutti, A., Bergamaschi, E., Fabbretti, G., Callea, F., ... Ghiggeri, G. M. (1993). Progression of chronic adriamycin nephropathy in leukopenic rats. Nephron, 63(1), 79-88.

Progression of chronic adriamycin nephropathy in leukopenic rats. / Ginevri, F.; Trivelli, A.; Mutti, A.; Bergamaschi, E.; Fabbretti, G.; Callea, F.; Salvidio, G.; Altieri, P.; Perfumo, F.; Ghiggeri, G. M.

In: Nephron, Vol. 63, No. 1, 1993, p. 79-88.

Research output: Contribution to journalArticle

Ginevri, F, Trivelli, A, Mutti, A, Bergamaschi, E, Fabbretti, G, Callea, F, Salvidio, G, Altieri, P, Perfumo, F & Ghiggeri, GM 1993, 'Progression of chronic adriamycin nephropathy in leukopenic rats', Nephron, vol. 63, no. 1, pp. 79-88.
Ginevri F, Trivelli A, Mutti A, Bergamaschi E, Fabbretti G, Callea F et al. Progression of chronic adriamycin nephropathy in leukopenic rats. Nephron. 1993;63(1):79-88.
Ginevri, F. ; Trivelli, A. ; Mutti, A. ; Bergamaschi, E. ; Fabbretti, G. ; Callea, F. ; Salvidio, G. ; Altieri, P. ; Perfumo, F. ; Ghiggeri, G. M. / Progression of chronic adriamycin nephropathy in leukopenic rats. In: Nephron. 1993 ; Vol. 63, No. 1. pp. 79-88.
@article{a002a17809334bb8b3689c9684db9e36,
title = "Progression of chronic adriamycin nephropathy in leukopenic rats",
abstract = "In this study, we examined the progression of chronic Adriamycin (ADR) nephropathy in mild leukopenic rats and tried to define the possible relationship between tubulointerstitial lesions and proteinuria in this model. Chronic ADR nephropathy was induced by 2 doses of ADR (2mg/kg) in 32 Sprague-Dawley rats. Eight of these were randomly assigned to cyclophosphamide treatment (50mg/kg), given intravenously every week, to keep the blood leukocyte count constantly lower than 5,000/mm3. Serial parameters were followed for 16 weeks including clearance studies with iothalamate and p-aminohippurate and the analysis of urinary protein composition by: (a) an enzymatic assay for β-glucosidase; (b) specific ELISA using antibodies against rat albumin and RBP, and finally (c) two-dimensional electrophoresis. ADR-treated rats rapidly (within 2 weeks) developed massive proteinuria which was in constant increment throughout the disease evolution in each single component (i.e., high and low molecular weight proteinuria, enzymuria) and developed renal insufficiency. At week 8, in ADR rats, glomerulosclerosis was mild whereas tubulointerstitial infiltrates predominated, characterized mainly by CD4 + T lymphocytes while CD8 + T lymphocytes were inconspicuous, and macrophages were only occasionally present. All such alterations had worsened after 16 weeks when the tubulointerstitial infiltration was associated with marked interstitial fibrosis and tubular atrophy. Leukopenia induced by cyclophosphamide was in all cases associated with a net amelioration of renal histopathology reducing tubulointerstitial infiltrates (by 40{\%}) and glomerulosclerosis (33±5 vs. 52.2±7.5{\%} sclerotic glomeruli) and also ameliorated glomerular filtration indexes (C(I) 780±40 vs. 447±66μl/min/kg-1). In spite of these differences, albuminuria and urinary-retinol-binding protein were comparable at weeks 4, 8 and 16 in this group, while urinary β-glucosidase was decreased at week 16 (p",
keywords = "Adriamycin nephropathy, Leukopenic rats, Progression of renal disease, Proteinuria, Tubulointerstitial fibrosis",
author = "F. Ginevri and A. Trivelli and A. Mutti and E. Bergamaschi and G. Fabbretti and F. Callea and G. Salvidio and P. Altieri and F. Perfumo and Ghiggeri, {G. M.}",
year = "1993",
language = "English",
volume = "63",
pages = "79--88",
journal = "Experimental Nephrology",
issn = "0028-2766",
publisher = "S. Karger AG",
number = "1",

}

TY - JOUR

T1 - Progression of chronic adriamycin nephropathy in leukopenic rats

AU - Ginevri, F.

AU - Trivelli, A.

AU - Mutti, A.

AU - Bergamaschi, E.

AU - Fabbretti, G.

AU - Callea, F.

AU - Salvidio, G.

AU - Altieri, P.

AU - Perfumo, F.

AU - Ghiggeri, G. M.

PY - 1993

Y1 - 1993

N2 - In this study, we examined the progression of chronic Adriamycin (ADR) nephropathy in mild leukopenic rats and tried to define the possible relationship between tubulointerstitial lesions and proteinuria in this model. Chronic ADR nephropathy was induced by 2 doses of ADR (2mg/kg) in 32 Sprague-Dawley rats. Eight of these were randomly assigned to cyclophosphamide treatment (50mg/kg), given intravenously every week, to keep the blood leukocyte count constantly lower than 5,000/mm3. Serial parameters were followed for 16 weeks including clearance studies with iothalamate and p-aminohippurate and the analysis of urinary protein composition by: (a) an enzymatic assay for β-glucosidase; (b) specific ELISA using antibodies against rat albumin and RBP, and finally (c) two-dimensional electrophoresis. ADR-treated rats rapidly (within 2 weeks) developed massive proteinuria which was in constant increment throughout the disease evolution in each single component (i.e., high and low molecular weight proteinuria, enzymuria) and developed renal insufficiency. At week 8, in ADR rats, glomerulosclerosis was mild whereas tubulointerstitial infiltrates predominated, characterized mainly by CD4 + T lymphocytes while CD8 + T lymphocytes were inconspicuous, and macrophages were only occasionally present. All such alterations had worsened after 16 weeks when the tubulointerstitial infiltration was associated with marked interstitial fibrosis and tubular atrophy. Leukopenia induced by cyclophosphamide was in all cases associated with a net amelioration of renal histopathology reducing tubulointerstitial infiltrates (by 40%) and glomerulosclerosis (33±5 vs. 52.2±7.5% sclerotic glomeruli) and also ameliorated glomerular filtration indexes (C(I) 780±40 vs. 447±66μl/min/kg-1). In spite of these differences, albuminuria and urinary-retinol-binding protein were comparable at weeks 4, 8 and 16 in this group, while urinary β-glucosidase was decreased at week 16 (p

AB - In this study, we examined the progression of chronic Adriamycin (ADR) nephropathy in mild leukopenic rats and tried to define the possible relationship between tubulointerstitial lesions and proteinuria in this model. Chronic ADR nephropathy was induced by 2 doses of ADR (2mg/kg) in 32 Sprague-Dawley rats. Eight of these were randomly assigned to cyclophosphamide treatment (50mg/kg), given intravenously every week, to keep the blood leukocyte count constantly lower than 5,000/mm3. Serial parameters were followed for 16 weeks including clearance studies with iothalamate and p-aminohippurate and the analysis of urinary protein composition by: (a) an enzymatic assay for β-glucosidase; (b) specific ELISA using antibodies against rat albumin and RBP, and finally (c) two-dimensional electrophoresis. ADR-treated rats rapidly (within 2 weeks) developed massive proteinuria which was in constant increment throughout the disease evolution in each single component (i.e., high and low molecular weight proteinuria, enzymuria) and developed renal insufficiency. At week 8, in ADR rats, glomerulosclerosis was mild whereas tubulointerstitial infiltrates predominated, characterized mainly by CD4 + T lymphocytes while CD8 + T lymphocytes were inconspicuous, and macrophages were only occasionally present. All such alterations had worsened after 16 weeks when the tubulointerstitial infiltration was associated with marked interstitial fibrosis and tubular atrophy. Leukopenia induced by cyclophosphamide was in all cases associated with a net amelioration of renal histopathology reducing tubulointerstitial infiltrates (by 40%) and glomerulosclerosis (33±5 vs. 52.2±7.5% sclerotic glomeruli) and also ameliorated glomerular filtration indexes (C(I) 780±40 vs. 447±66μl/min/kg-1). In spite of these differences, albuminuria and urinary-retinol-binding protein were comparable at weeks 4, 8 and 16 in this group, while urinary β-glucosidase was decreased at week 16 (p

KW - Adriamycin nephropathy

KW - Leukopenic rats

KW - Progression of renal disease

KW - Proteinuria

KW - Tubulointerstitial fibrosis

UR - http://www.scopus.com/inward/record.url?scp=0027434735&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027434735&partnerID=8YFLogxK

M3 - Article

VL - 63

SP - 79

EP - 88

JO - Experimental Nephrology

JF - Experimental Nephrology

SN - 0028-2766

IS - 1

ER -